Quantifying allodynia in patients suffering from unilateral neuropathic pain using von Frey monofilaments

Clinical Journal of Pain

Volumn 23, Issue 1, 2007, Pages 85-90

  Keizer, Doeke ^a   Van Wijhe, Marten ^a   Post, Wendy J ^a   Wierda, J Mark K H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Allodynia; Neuropathic pain; Threshold; Von Frey monofilament

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; FEMALE; HUMAN; HYPERESTHESIA; MALE; MIDDLE AGED; NEURALGIA; PAIN THRESHOLD; PATHOPHYSIOLOGY; STIMULATION;

ADULT; AGED; CHRONIC DISEASE; FEMALE; HUMANS; HYPERESTHESIA; MALE; MIDDLE AGED; NEURALGIA; PAIN THRESHOLD; PHYSICAL STIMULATION;

EID: 33847303159     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/01.ajp.0000210950.01503.72     Document Type: Article

References (35)

1. Chong MS, Bajwa ZH. Diagnosis and treatment of neuropathic pain. J Pain Symptom Manage. 2003;25:S4-S11.
2. Bridges D, Thompson SWN, Rice ASC. Mechanisms of neuropathic pain. Br J Anaesth. 2001;87:12-26.
3. Macres SM, Richeimer SH, Duran PJ. The pathophysiology and treatment of neuropathic pain. Am Soc Anesthesiol. 1999;27: 109-121.
4. Verdugo R, Ochoa JL. Quantitative Somatosensory Thermotest. A key method for functional evaluation of small calibre afferent channels. Brain. 1992;115:893-913.
5. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959-64.
6. Merskey H, Bogduk N, eds. Classification of Chronic Pain. Seattle: IASP Press; 1994.
7. Backonja MM. Painful neuropathies. In: Loeser JD, Butler SD, Chapman CR, et al, eds. Bonica's Management of Pain. Philidelphia: Lippincott Williams & Wilkins; 2002:371-387.
8. Hansson P, Lacerenza M, Marchettini P. Aspects of clinical and experimental neuropathic pain: the clinical perspective. In: Hansson PT, Fields HL, Hill RG, et al, eds. Neuropathic Pain: Pathophysiology and Treatment, Progress in Pain Research and Management. Seattle: IASP Press; 2001:1-18.
9. McQuay HJ, Moore RA. Anticonvulsant drugs. In: McQuay HJ, Moore RA, eds. An Evidence-based Resource for Pain. Oxford: Oxford University Press; 1998:221-230.
10. McQuay HJ, Moore RA. Antidepressants in neuropathic pain. In: McQuay HJ, Moore RA, eds. An Evidence-based Resource for Pain. Oxford: Oxford University Press; 1998: 231-241.
11. Olaleye D, Perkins BA, Bril V. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Pract. 2001; 54:115-128.
12. Perkins BA, Olaleye D, Zinman B, et al. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care. 2001;24:250-256.
13. LaMotte RH, Shain CN, Simone DA, et al. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J Neurophysiol. 1991;66:190-211.
14. Maihöfner C, Forster C, Birklein F, et al. Brain processing during mechanical hyperalgesia in complex regional pain syndrome: a functional MRI study. Pain. 2005;114:93-103.
15. Zambreanu I, Wise RG, Brooks JCW, et al. A role for the brainstem in central sensitisation in humans. Evidence from functional magnetic resonance imaging. Pain. 2005;114:397-407.
16. Johanek LM, Heitmiller DR, Turner M, et al. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms. Pain. 2001;93:303-315.
17. Martin WJ, Loo CM, Basbaum AI. Spinal cannabinoids are anti-allodynic in rats with persistent inflammation. Pain. 1999; 82:199-205.
18. Bell-Krotoski J, Tomancik E. The repeatability of testing with Semmes-Weinstein monofilaments. J Hand Surg. 1987;12A:155-161.
19. Bell-Krotoski JA, Ewing Fess E, Figarola JH, et al. Threshold detection and Semmes-Weinstein monofilaments. J Hand Ther. 1995;8:155-162.
20. Peripheral Neuropathy Association. Quantitative sensory testing: a consensus report from the Peripheral Neuropathy Association. Neurology. 1993;43:1050-1052.
21. Gottrup H, Nielsen J, Arendt-Nielsen L, et al. The relationship between sensory thresholds and mechanical hyperalgesia in nerve injury. Pain. 1998;75:321-329.
22. Graven-Nielsen T, Sergerdahl M, Svensson P, et al. Methods for induction and assessment of pain in humans with clinical and pharmacological examples. In: Kruger L, ed. Methods in Pain Research. London: CRC Press; 2001:263-304.
23. Warncke T, Stubhaug A, Jørum E. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain. 1997; 72:99-106.
24. Ziegler EA, Magerl W, Meyer RA, et al. Secondary hyperalgesia to punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input. Brain. 1999;122:2245-2257.
25. Dotson RM. Clinical neurophysiology laboratory tests to assess the nociceptive system in humans. J Clin Neurophysiol. 1997; 14:32-45.
26. Gruener G, Dyck PJ. Quantitative Sensory Testing: methodology, application, and future directions. J Clin Neurophysiol. 1994;11: 568-583.
27. Voerman VF, Egmond van J, Crul BJP. Elevated detection thresholds for mechanical stimuli in chronic pain patients: support for a central mechanism. Arch Phys Med Rehabil. 2000; 81:430-435.
28. Leung A, Wallace MS, Ridgeway B, et al. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain. 2001;91:177-187.
29. Price DD, Bennett GJ, Raffii A. Psychophysical observations on patients with neuropathic pain relieved by a sympathetic block. Pain. 1989;36:273-288.
30. Bohm-Starke N, Hilliges M, Brodda-Jansen G, et al. Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome. Pain. 2001;94:177-183.
31. Wallace MS, Barger D, Schulteis G. The effect of chronic oral desipramine on capsaicin-induced allodynia and hyperalgesia: a double-blinded, placebo-controlled, crossover study. Anesth Analg. 2002;95:973-978.
32. Schulte H, Sollevi A, Segerdahl M. Dose-dependent effects of morphine on experimentally induced cutaneous pain in healthy volunteers. Pain. 2005;116:366-374.
33. Koppert W, Filitz J, Troster A, et al. Activation of naloxonesensitive and -insensitive inhibitory systems in a human pain model. J Pain. 2005;6:757-764.
34. Belfrage M, Sollevi A, Segerdahl M. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth Analg. 1995; 81:713-717.
35. Wallace MS, Rowbotham M, Bennett GJ, et al. A multicenter, double-blind, randomized, placebo-controlled crossover evaluation of a short course of 4030W92 in patients with chronic neuropathic pain. J Pain. 2002;3:227-233.